Vertex (VRTX) EVP and CMO reports 3,804-share tax-withholding disposition

Rhea-AI Filing Summary

Vertex Pharmaceuticals executive reports tax-withholding share disposition. EVP and CMO Carmen Bozic disposed of 3,804 shares of Vertex Pharmaceuticals common stock on a tax-withholding basis at $487.76 per share. After this tax-withholding disposition, she directly holds 38,053 shares of Vertex common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bozic Carmen

Role EVP and CMO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	3,804	$487.76	$1.86M

Holdings After Transaction: Common Stock — 38,053 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bozic Carmen

(Last) (First) (Middle)

C/O VERTEX PHARMACEUTICALS INCORPORATED

50 NORTHERN AVENUE

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CMO

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		3,804	D	$487.76	38,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Christiana Stevenson, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vertex (VRTX) report for Carmen Bozic?

Vertex reported a tax-withholding disposition by EVP and CMO Carmen Bozic. She disposed of 3,804 shares of common stock to cover tax obligations and now directly holds 38,053 Vertex shares following this non-open-market transaction.

Was the Carmen Bozic transaction in Vertex (VRTX) stock an open-market sale?

No, the transaction was a tax-withholding disposition coded “F.” This means shares were withheld or delivered to satisfy tax liabilities, rather than sold by Carmen Bozic in an open-market transaction on an exchange.

How many Vertex (VRTX) shares did Carmen Bozic dispose of and at what price?

Carmen Bozic disposed of 3,804 shares of Vertex common stock at $487.76 per share. The transaction is classified as a tax-withholding disposition, used to cover tax obligations tied to equity compensation.

How many Vertex (VRTX) shares does Carmen Bozic hold after this Form 4 transaction?

After the reported transaction, Carmen Bozic directly holds 38,053 Vertex common shares. This figure reflects her ownership following the 3,804-share tax-withholding disposition reported in the Form 4 insider filing.

What does transaction code “F” mean in the Vertex (VRTX) Form 4 for Carmen Bozic?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering securities. In this case, 3,804 Vertex shares were disposed of by Carmen Bozic to satisfy tax obligations rather than through a discretionary market sale.